In general, AML-related mutations tend to occur in an ordered manner, with mutations in epigenetic modifier-encoding genes including DNMT3A, ASXL1, TET2, IDH1, and IDH2 most often occurring early in the diseases. This evidence concerns the gene TET2 and acute myeloid leukemia.